Abstract:Summary1. Isoliquiritigenin (ISL) is a simple chalcone‐type flavonoid derived from liquorice compounds. It has been reported to have anti‐oxidative and antitumour activities. The aim of the present study was to investigate the antitumour effect of ISL on prostate cancer cells and to explore the possible signalling mechanisms involved.2. Cell viability was assessed using the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay. The fluorescent probe 2′,7′‐dichlorofluorescein diacetate (H2DCF‐DA) was used to measure intracellular levels of reactive oxygen species (ROS). Mitochondrial membrane potential (Ψm) was measured using the mitochondrial probe 5,5′,6,6′‐tetrachloro‐1,1′,3,3′‐tetraethyl‐benzimidazolylcarbocyanine iodide (JC‐1).3. Isoliquiritigenin treatment (10–100 μmol/L for 24 h) markedly inhibited the proliferation of both C4‐2 and LNCaP prostate cancer cells in a dose‐dependent manner. Intriguingly, ISL treatment (10–100 μmol/L for 24 h) had no effect on the viability of IEC‐6 normal epithelial cells. Treatment of C4‐2 and IEC‐6 cells with 87.0 μmol/L ISL significantly decreased ROS levels and the Ψm of C4‐2 cells, but had no effect on either parameter in IEC‐6 cells. Furthermore, AMP‐activated protein kinase (AMPK) and extracellular‐signal regulated kinase (ERK) levels were three to fourfold higher in IEC‐6 cells than in C4‐2 cells (P < 0.05).4. The results of the present study suggest that ISL, a natural anti‐oxidant, selectively inhibits the proliferation of prostate cancer C4‐2 cells, which may be attributed, in part, to defective AMPK and ERK signalling pathways in C4‐2 compared with IEC‐6 cells.

Design, Synthesis, and Antitumor Activity of Isoliquiritigenin Amino Acid Ester Derivatives

Isoliquiritigenin (ISL) and its formulations: potential antitumor agents.

Isoliquiritigenin, A Natural Anti-Oxidant, Selectively Inhibits the Proliferation of Prostate Cancer Cells

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthetic Isoliquiritigenin Inhibits Human Tongue Squamous Carcinoma Cells through Its Antioxidant Mechanism

Design and Synthesis of C-19 Isosteviol Derivatives As Potent and Highly Selective Antiproliferative Agents

Design, Preparation and Studies Regarding Cytotoxic Properties of Glycyrrhetinic Acid Derivatives.

Design and Synthesis of the Novel Oleanolic Acid-Cinnamic Acid Ester Derivatives and Glycyrrhetinic Acid-Cinnamic Acid Ester Derivatives with Cytotoxic Properties

ISL Induces Apoptosis and Autophagy in Hepatocellular Carcinoma Via Downregulation of PI3K/AKT/mTOR Pathway in Vivo and in Vitro

Design, Synthesis and Antitumor Activity of 3,4,5-Trisubstituted Isoxazoles

Design, synthesis, and cytotoxic activities of isaindigotone derivatives as potential anti-gastric cancer agents

Design, Synthesis and Anti-Gastric Carcinoma Activity of 1-Styryl Isoquinoline Derivatives

Synthesis and Biological Evaluation of New Ligustrazine Derivatives As Anti-Tumor Agents

Design, synthesis and biological evaluation of novel 1,5-disubstituted isatin derivatives as antitumor agents

Design, synthesis and antitumor evaluation of novel 1H-indole-2-carboxylic acid derivatives targeting 14-3-3η protein

Chemical Synthesis and Antitumor Evaluation of Chikusetsusaponin IVa Butyl Ester and Its Analogues

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Design, Synthesis, and Anticancer Activity Studies of Novel Quinoline-Chalcone Derivatives

Synthesis and Antitumor Activity Evaluation of Novel Ursolic Acid Derivatives

Design, Synthesis, and Antitumor Evaluation of Novel Naphthalimide Derivatives